| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/11/2004 | US6734179 Sulfur compounds such as 4-fluoro-n-(4-methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-yl) -benzamide, used as preferential adenosine receptor ligands for the prophylaxis of neurodegenerative disorders |
| 05/11/2004 | US6733982 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 05/11/2004 | CA2136999C Peripheral vasodilating agent containing piperidine derivative as active ingredient |
| 05/06/2004 | WO2004038374A2 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 05/06/2004 | WO2004037820A1 Oxindole substituted piperazine derivatives |
| 05/06/2004 | WO2004037819A1 Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
| 05/06/2004 | WO2004037818A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 05/06/2004 | WO2004037817A1 N-oxide compounds |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037789A2 Methylene urea derivatives as raf-kinase inhibitors |
| 05/06/2004 | WO2004037784A2 Pyrrolidones with anti-hiv activity |
| 05/06/2004 | WO2004037251A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/06/2004 | WO2004037250A1 4-alkenylthiazoles comprising epoxide functionality, and methods of use thereof |
| 05/06/2004 | WO2004037247A1 Oxindoles with anti-hiv activity |
| 05/06/2004 | WO2004037176A2 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 05/06/2004 | WO2004028441A3 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 05/06/2004 | WO2004026822A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 05/06/2004 | WO2004018463A3 Pyridyl substituted heterocycles useful for treating or preventing hcv infection |
| 05/06/2004 | WO2004013131A3 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
| 05/06/2004 | WO2004011460A3 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 05/06/2004 | WO2004005281A8 Inhibitors of tyrosine kinases |
| 05/06/2004 | WO2003097604A9 Pyridine carboxamide derivatives and their use as pesticides |
| 05/06/2004 | WO2003082853A8 New compounds |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | WO2003004467A3 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 05/06/2004 | WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 05/06/2004 | WO2002020512A9 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 05/06/2004 | US20040087787 Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds |
| 05/06/2004 | US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 05/06/2004 | US20040087635 Administering insulin sensitizer; benign prostatic hyperplasia |
| 05/06/2004 | US20040087634 Antitumor agents; plant safening agents |
| 05/06/2004 | US20040087633 Methylidene oxazolidinone compound and preparation method thereof |
| 05/06/2004 | US20040087629 Tartrate salts of thiazolidinedione derivative |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087626 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
| 05/06/2004 | US20040087623 Pyrazole derivatives against tgf overexpression |
| 05/06/2004 | US20040087595 1-aryl- or 1-alkylsulfony-heterocyclybenzazoles as 5-hydroxytryptamine-6 ligands |
| 05/06/2004 | US20040087594 Diaminothiazoles having antiproliferative activity |
| 05/06/2004 | US20040087588 Parp inhibitors |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087577 Anti-infective agents |
| 05/06/2004 | US20040087575 Therapeutic chromone compounds |
| 05/06/2004 | US20040087568 Substituted anthranilic amide derivatives and methods of use |
| 05/06/2004 | US20040087548 Anticancer agents and treating immune disorders |
| 05/06/2004 | US20040086746 Organic light emitting diode and organic luminescent materials thereof |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1414818A1 Azole derivatives useful as insecticide |
| 05/06/2004 | EP1414814A1 6-aryl-4-aminopicolinates and their use as herbicides |
| 05/06/2004 | EP1414813A1 1,2,4-trioxolane antimalarials |
| 05/06/2004 | EP1414809A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 05/06/2004 | EP1414805A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
| 05/06/2004 | EP1414802A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414456A1 Phenyl derivatives as factor xa inhibitors |
| 05/06/2004 | EP1414447A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 05/06/2004 | EP1414384A2 Synthesis of epothilones and relates analogs |
| 05/06/2004 | EP1305307B1 Indole derivatives useful for the treatment of cns disorders |
| 05/06/2004 | EP1280802B1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 05/06/2004 | EP1261600B1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1117645B1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
| 05/06/2004 | EP0980203A4 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 05/06/2004 | EP0880568B1 Electrochromic system |
| 05/06/2004 | CA2503471A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 05/06/2004 | CA2503245A1 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 05/06/2004 | CA2501228A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/06/2004 | CA2498215A1 Oxindole substituted piperazine derivatives |
| 05/05/2004 | CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/05/2004 | CN1494530A Heterocyclic diamide invertebrate pest control agents |
| 05/05/2004 | CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 05/05/2004 | CN1148351C Compound for curing vascular complication, its preparing method and treating use |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 05/05/2004 | CN1148189C Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors |
| 05/04/2004 | US6730803 Production method of a beta -keto ester compound of claim 1, which comprises condensation of a 2-cyano-2,2-dimethylacetate solution to give 2-cyano-2,2- dimethylacetate of the formula (ii), and condensation thereof |
| 05/04/2004 | US6730794 Substituted indolealkanoic acids |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 05/04/2004 | US6730677 Treating memory impairment; enhance excitatory synaptic activity in order to restore an imbalance between brain subregions, as in treatment of schizophrenia or schizophreniform behavior. |
| 04/29/2004 | WO2004035571A1 Substituted indoles and their use as hcv inhibitors |
| 04/29/2004 | WO2004035569A2 Novel compounds with antibacterial activity |
| 04/29/2004 | WO2004035549A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 04/29/2004 | WO2004035543A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/29/2004 | WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 04/29/2004 | WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 04/29/2004 | WO2003101373A3 Thiazolidinedione derivatives in therapeutic and prophylactic methods |
| 04/29/2004 | WO2003060078A8 Heterocyclic modulators of nuclear receptors |
| 04/29/2004 | WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082785 Process for making an aldehyde |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082651 Epothilone synthesis building blocks III and IV: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones B, D and epothilone derivatives |
| 04/29/2004 | US20040082638 Compounds, compositions and methods |
| 04/29/2004 | US20040082636 Method for the prophylaxis or treatment of glomerulonephritis |